The interval of the paired ergometric stress tests is two weeks in both cases. Protocol means the combination of starting exercise intensity (Watt) and incremental exercise intensity (Watt). Heart rate (bpm) and blood pressure (mmHg) indicate the two values immediately before starting exercise and at the end of the exercise, respectively. *: Heart rate at the end of exercise was estimated under AF in Case 1. AF: atrial fibrillation; METS: metabolic equivalents; PVC: premature ventricular contraction; SVPC: supraventricular premature contraction; THR: target heart rate (bpm: beats per minute).
Declarations
Acknowledgments
All authors acknowledge the nursing, laboratory, and rehabilitation staff taking care of the participants described.
Author contributions
TM: Conceptualization, Writing—original draft. YY: Data curation, Formal analysis, Investigation. MH: Data curation, Formal analysis, Writing—review & editing, Supervision. All authors read and approved the submitted version.
Conflicts of interest
The authors declare that they have no conflicts of interest.
Ethical approval
This study complied with the Declaration of Helsinki. Ethical approval for this study was waived by the Internal Ethics Committee under the condition of secure personal data protection and compliance with privacy policy, because the examinations and treatment of two cases were followed strictly by the Regulation of Japanese Healthcare Insurance.
Consent to participate
Informed consent to participate in this study was obtained from participants and guardians.
Consent to publication
Informed consent to publication was obtained from participants and guardians.
Availability of data and materials
The datasets of this manuscript could be available from the corresponding authors upon reasonable request to Toru Maruyama (tmaruyama@haradoi-hospital.com).
Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.
References
Guasch E, Mont L. Diagnosis, pathophysiology, and management of exercise-induced arrhythmias.Nat Rev Cardiol. 2017;14:88–101. [DOI] [PubMed]
Goodman JM, Burr JF, Banks L, Thomas SG. The Acute Risks of Exercise in Apparently Healthy Adults and Relevance for Prevention of Cardiovascular Events.Can J Cardiol. 2016;32:523–32. [DOI] [PubMed]
Sandau KE, Funk M, Auerbach A, Barsness GW, Blum K, Cvach M, et al.; American Heart Association Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology, Council on Cardiovascular Disease in the Young. Update to Practice Standards for Electrocardiographic Monitoring in Hospital Settings: A Scientific Statement From the American Heart Association.Circulation. 2017;136:e273–344. [DOI] [PubMed]
Muresan L, Cismaru G, Muresan C, Rosu R, Gusetu G, Puiu M, et al. Beta-blockers for the treatment of arrhythmias: Bisoprolol—a systematic review.Ann Pharm Fr. 2022;80:617–34. [DOI] [PubMed]
Ono K, Iwasaki YK, Akao M, Ikeda T, Ishii K, Inden Y, et al.; Japanese Circulation Society and Japanese Heart Rhythm Society Joint Working Group. JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias.Circ J. 2022;86:1790–924. [DOI] [PubMed]
Wiecha S, Kasiak PS, Szwed P, Kowalski T, Cieśliński I, Postuła M, et al. VO2max prediction based on submaximal cardiorespiratory relationships and body composition in male runners and cyclists: a population study.Elife. 2023;12:e86291. [DOI] [PubMed] [PMC]
Costantini M, Elizari MV, Previtali M, Sciarra L, Luzza F, Costantini L, et al. Endurance sport and atrial fibrillation: a mini-review of a complex relationship.Explor Cardiol. 2025;3:101267. [DOI]
Elliott AD, Linz D, Verdicchio CV, Sanders P. Exercise and Atrial Fibrillation: Prevention or Causation?Heart Lung Circ. 2018;27:1078–85. [DOI] [PubMed]
Sramko M, Wichterle D, Melenovsky V, Clemens M, Fukunaga M, Peichl P, et al. Resting and Exercise-Induced Left Atrial Hypertension in Patients With Atrial Fibrillation: The Causes and Implications for Catheter Ablation.JACC Clin Electrophysiol. 2017;3:461–9. [DOI] [PubMed]
Sezai A, Nakai T, Hata M, Yoshitake I, Shiono M, Kunimoto S, et al. Feasibility of landiolol and bisoprolol for prevention of atrial fibrillation after coronary artery bypass grafting: a pilot study.J Thorac Cardiovasc Surg. 2012;144:1241–8. [DOI] [PubMed]
Ishiguro H, Ikeda T, Abe A, Tsukada T, Mera H, Nakamura K, et al. Antiarrhythmic effect of bisoprolol, a highly selective beta1-blocker, in patients with paroxysmal atrial fibrillation.Int Heart J. 2008;49:281–93. [DOI] [PubMed]
Lin C, Zheng C, Zhou DP, Li XW, Wu SJ, Lin JF. Origins location of the outflow tract ventricular arrhythmias exhibiting qrS pattern or QS pattern with a notch on the descending limb in lead V1.BMC Cardiovasc Disord. 2017;17:124. [DOI] [PubMed] [PMC]
Nikoo MH, Taheri S, Attar A. A novel ECG criterion to differentiate left from right ventricular outflow tract premature complex.Scand Cardiovasc J. 2020;54:139–45. [DOI] [PubMed]
Lu YY, Chen YC, Lin YK, Chen SA, Chen YJ. Electrical and Structural Insights into Right Ventricular Outflow Tract Arrhythmogenesis.Int J Mol Sci. 2023;24:11795. [DOI] [PubMed] [PMC]
Krittayaphong R, Bhuripanyo K, Punlee K, Kangkagate C, Chaithiraphan S. Effect of atenolol on symptomatic ventricular arrhythmia without structural heart disease: a randomized placebo-controlled study.Am Heart J. 2002;144:e10. [DOI] [PubMed]
Weiss S, Oz S, Benmocha A, Dascal N. Regulation of cardiac L-type Ca²⁺ channel CaV1.2 via the β-adrenergic-cAMP-protein kinase A pathway: old dogmas, advances, and new uncertainties.Circ Res. 2013;113:617–31. [DOI] [PubMed]
Holt PM, Wainwright RJ, Curry PV. Right ventricular outflow tract tachycardias in patients without apparent structural heart disease.Int J Cardiol. 1986;10:99–110. [DOI] [PubMed]
Francisco AC, Awata WMC, Lima TS, Potje SR, Prohaska CC, Ceron CS, et al. Three Generation β-Blockers for Atrial Fibrillation Treatment.Curr Hypertens Rev. 2023;19:34–41. [DOI] [PubMed]
Valentini M, Revera M, Bilo G, Caldara G, Savia G, Styczkiewicz K, et al. Effects of beta-blockade on exercise performance at high altitude: a randomized, placebo-controlled trial comparing the efficacy of nebivolol versus carvedilol in healthy subjects.Cardiovasc Ther. 2012;30:240–8. [DOI] [PubMed]
Beloka S, Gujic M, Deboeck G, Niset G, Ciarka A, Argacha JF, et al. Beta-adrenergic blockade and metabo-chemoreflex contributions to exercise capacity.Med Sci Sports Exerc. 2008;40:1932–8. [DOI] [PubMed]
Kindermann M, Seeland U, Ruhnke P, Böhm M, Maack C. Functional effects of β₁-adrenoceptor polymorphisms on the hemodynamic response to dobutamine with and without β-blocker administration.Clin Res Cardiol. 2011;100:129–37. [DOI] [PubMed]
Nielen JTH, de Vries F, van der Velde JHPM, Savelberg HHCM, Schaper NC, Dagnelie PC, et al. The Association Between β-Blocker Use and Cardiorespiratory Fitness: The Maastricht Study.J Cardiovasc Pharmacol Ther. 2019;24:37–45. [DOI] [PubMed] [PMC]
Marti HP, Pavía López AA, Schwartzmann P. Safety and tolerability of β-blockers: importance of cardioselectivity.Curr Med Res Opin. 2024;40:55–62. [DOI] [PubMed]
Spoladore R, Fragasso G, Perseghin G, De Cobelli F, Esposito A, Maranta F, et al. Beneficial effects of beta-blockers on left ventricular function and cellular energy reserve in patients with heart failure.Fundam Clin Pharmacol. 2013;27:455–64. [DOI] [PubMed]
Issa VS, Guimarães GV, Rezende MVC, Cruz FdD, Ferreira SMA, Bacal F, et al. Effects of bisoprolol on cardiac function and exercise in patients with heart failure.Arq Bras Cardiol. 2007;88:340–5. [DOI] [PubMed]
